What is he best known for?
The fields of study he is best known for:
Virology, Immunology, Measles virus, Virus and Immune system are his primary areas of study.
As a part of the same scientific study, Rik L. de Swart usually deals with the Virology, concentrating on Antigen and frequently concerns with Respiratory virus.
His research in Vaccination, Antibody and Immunosuppression are components of Immunology.
His work in Measles virus addresses subjects such as Antigen-presenting cell, which are connected to disciplines such as Lymph node.
His Virus research includes themes of Vaccinia, Middle East respiratory syndrome and Lung, Type-II Pneumocytes.
His study focuses on the intersection of Immune system and fields such as Measles with connections in the field of Pathogen and Humoral immunity.
His most cited work include:
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. (433 citations)
- Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. (330 citations)
- Antigenic and Genetic Variability of Human Metapneumoviruses (301 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Virology, Measles virus, Immunology, Virus and Measles.
Within one scientific family, Rik L. de Swart focuses on topics pertaining to Immunogenicity under Virology, and may sometimes address concerns connected to Vaccinia.
His Measles virus study integrates concerns from other disciplines, such as Pathogenesis, Viremia, DC-SIGN, Tissue tropism and Rash.
The various areas that Rik L. de Swart examines in his Virus study include Respiratory tract, Lung and Microbiology.
The study incorporates disciplines such as Epidemiology, Viral disease, Transmission, Disease and Serology in addition to Measles.
His study on Vaccination also encompasses disciplines like
- Immunization, which have a strong connection to Human metapneumovirus,
- Recombinant virus which connect with Immunopathology.
He most often published in these fields:
- Virology (68.00%)
- Measles virus (45.60%)
- Immunology (38.40%)
What were the highlights of his more recent work (between 2017-2021)?
- Measles virus (45.60%)
- Virology (68.00%)
- Measles (31.20%)
In recent papers he was focusing on the following fields of study:
Rik L. de Swart mostly deals with Measles virus, Virology, Measles, Immune system and Immunology.
His studies in Measles virus integrate themes in fields like Pathogenesis, Immunity, Attack rate, Subclinical infection and Rash.
His study in Order Mononegavirales and Virus is carried out as part of his Virology studies.
His Measles research is within the category of Vaccination.
His Immune system study combines topics from a wide range of disciplines, such as Pathogen, Antibody and Rubella.
His study on CD8 and Viral pathogenesis is often connected to Amnesia as part of broader study in Immunology.
Between 2017 and 2021, his most popular works were:
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. (433 citations)
- Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. (330 citations)
- Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens (104 citations)
In his most recent research, the most cited papers focused on:
Virology, Immune system, Immunology, Taxonomy and Order Mononegavirales are his primary areas of study.
His Immune system research incorporates elements of Measles and Measles virus.
The Measles study combines topics in areas such as Pathogen and Naive B cell.
His Measles virus study deals with the bigger picture of Vaccination.
Rik L. de Swart is interested in CD8, which is a field of Immunology.
His Taxonomy study incorporates themes from Evolutionary biology, Taxon, Species complex, Phylogenetics and Mononegavirales.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
